866-997-4948(US-Canada Toll Free)

Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 44 Pages


Delcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic liver cancers. Delcath\'s patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient\'s bloodstream. Its clinical trial product, the Delcath Percutaneous Hepatic Perfusion System (the Delcath PHP System), also known as Hepatic Chemosaturation therapy allows physicians to deliver ultra-high doses of anti-cancer agents to the liver while controlling their systemic exposure. Delcath is headquartered in New York City, New York, the US.

This report is a source for data, analysis and actionable intelligence on the Delcath Systems, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Delcath Systems, Inc. - Business Description 5

Key Facts 6
Delcath Systems, Inc. - Major Products and Services 7
Delcath Systems, Inc. Pipeline Products by Equipment Type 8
Delcath Systems, Inc. Pipeline Products by Development Stage 10
Delcath Systems, Inc. Pipeline Products by Therapy Area 12
Delcath Systems, Inc. Pipeline Products by Trial Phase 14
Delcath Systems, Inc. Pipeline Products by Milestone Summary 16
Chemotherapy Filter 20
Chemotherapy Filter Product Status 20
Chemotherapy Filter Product Description 20
Delcath Hepatic CHEMOSAT Delivery System 21
Delcath Hepatic CHEMOSAT Delivery System Product Status 21
Delcath Hepatic CHEMOSAT Delivery System Product Description 21
Delcath Hepatic CHEMOSAT Delivery System Product Milestone 21
Delcath Hepatic CHEMOSAT Delivery System Clinical Trial 22
Delcath Hepatic CHEMOSAT Delivery System Product Patent Details 27
Generation Two Hepatic CHEMOSAT Delivery System 29
Generation Two Hepatic CHEMOSAT Delivery System Product Status 29
Generation Two Hepatic CHEMOSAT Delivery System Product Description 29
Generation Two Hepatic CHEMOSAT Delivery System Product Milestone 29
Hepatic CHEMOSAT Delivery System - Doxorubicin 31
Hepatic CHEMOSAT Delivery System - Doxorubicin Product Status 31
Hepatic CHEMOSAT Delivery System - Doxorubicin Product Description 31
Hepatic CHEMOSAT Delivery System - Doxorubicin Product Milestone 31
Isolation Catheter System 33
Isolation Catheter System Product Status 33
Isolation Catheter System Product Description 33
Delcath Systems, Inc. - Key Competitors 34
Delcath Systems, Inc. - Key Employees 35
Delcath Systems, Inc. - Key Employee Biographies 36
Delcath Systems, Inc. - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Delcath Systems, Inc., Recent Developments 38
Nov 07, 2012: Delcath Reports Q3 2012 Results 38
Aug 08, 2012: Delcath Reports Q2 2012 Results 39
May 25, 2012: Delcath Opens European Headquarters In Galway, Ireland 39
May 08, 2012: Delcath Reports Revenue Of $14.9m In Q1 2012 39
Mar 08, 2012: Delcath Reports 2011 Results 40
Feb 13, 2012: Delcath Appoints Chris Houchins As Senior Vice President Of Clinical And Medical Affairs 41
Dec 28, 2011: Delcath\'s Ireland Operations Achieves ISO 13485 Certification 41
Dec 21, 2011: Delcath Appoints Gregory Gores To Medical Advisory Board 41
Nov 09, 2011: Delcath Reports Q3 2011 Results 42
Sep 26, 2011: Delcath Announces Management Changes 42

Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Table


Delcath Systems, Inc., Key Facts 1
Delcath Systems, Inc. Key Pipeline Products by Equipment Type 1
Delcath Systems, Inc. Key Pipeline Products by Therapy Area 1
Delcath Systems, Inc. Key Pipeline Products by Development Stage 1
Delcath Systems, Inc. Key Pipeline Products by Trial Phase 1
Delcath Systems, Inc., Key Facts 6
Delcath Systems, Inc., Major Products and Services 7
Delcath Systems, Inc. Number of Pipeline Products by Equipment Type 8
Delcath Systems, Inc. Pipeline Products by Equipment Type 9
Delcath Systems, Inc. Number of Pipeline Products by Development Stage 10
Delcath Systems, Inc. Pipeline Products by Development Stage 11
Delcath Systems, Inc. Number of Pipeline Products by Therapy Area 12
Delcath Systems, Inc. Pipeline Products by Therapy Area 13
Delcath Systems, Inc. Number of Pipeline Products by Trial Phase 14
Delcath Systems, Inc. Pipeline Products by Trial Phase 15
Delcath Systems, Inc. Number of Pipeline Products By Milestone Summary 16
Delcath Systems, Inc. Pipeline Products by Milestone Summary 17
Chemotherapy Filter - Product Status 20
Chemotherapy Filter - Product Description 20
Delcath Hepatic CHEMOSAT Delivery System - Product Status 21
Delcath Hepatic CHEMOSAT Delivery System - Product Description 21
Delcath Hepatic CHEMOSAT Delivery System - Product Milestone 21
Delcath Hepatic CHEMOSAT Delivery System - A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver 22
Delcath Hepatic CHEMOSAT Delivery System - A Phase II Study Of Hepatic Arterial Infusion Of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) For Unresectable Primary And Metastatic Cancers Of The Liver 24
Delcath Hepatic CHEMOSAT Delivery System - Patent Details1 27
Generation Two Hepatic CHEMOSAT Delivery System - Product Status 29
Generation Two Hepatic CHEMOSAT Delivery System - Product Description 29
Generation Two Hepatic CHEMOSAT Delivery System - Product Milestone 29
Hepatic CHEMOSAT Delivery System - Doxorubicin - Product Status 31
Hepatic CHEMOSAT Delivery System - Doxorubicin - Product Description 31
Hepatic CHEMOSAT Delivery System - Doxorubicin - Product Milestone 31
Isolation Catheter System - Product Status 33
Isolation Catheter System - Product Description 33
Delcath Systems, Inc., Key Employees 35
Delcath Systems, Inc., Key Employee Biographies 36
Delcath Systems, Inc., Other Locations 37
Delcath Systems, Inc., Subsidiaries 37

List of Chart


Delcath Systems, Inc. Pipeline Products by Equipment Type 8
Delcath Systems, Inc. Pipeline Products by Development Stage 10
Delcath Systems, Inc. Pipeline Products by Therapy Area 12
Delcath Systems, Inc. Pipeline Products by Trial Phase 14
Delcath Systems, Inc. Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *